Cargando…
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Upper tract urothelial carcinoma (UTUC) is characterized by a distinctly aggressive clinical phenotype. To define the biological features driving this phenotype, we performed an integrated analysis of whole-exome and RNA sequencing of UTUC. Here we report several key insights from our molecular diss...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611775/ https://www.ncbi.nlm.nih.gov/pubmed/31278255 http://dx.doi.org/10.1038/s41467-019-10873-y |
_version_ | 1783432760488099840 |
---|---|
author | Robinson, Brian D. Vlachostergios, Panagiotis J. Bhinder, Bhavneet Liu, Weisi Li, Kailyn Moss, Tyler J. Bareja, Rohan Park, Kyung Tavassoli, Peyman Cyrta, Joanna Tagawa, Scott T. Nanus, David M. Beltran, Himisha Molina, Ana M. Khani, Francesca Miguel Mosquera, Juan Xylinas, Evanguelos Shariat, Shahrokh F. Scherr, Douglas S. Rubin, Mark A. Lerner, Seth P. Matin, Surena F. Elemento, Olivier Faltas, Bishoy M. |
author_facet | Robinson, Brian D. Vlachostergios, Panagiotis J. Bhinder, Bhavneet Liu, Weisi Li, Kailyn Moss, Tyler J. Bareja, Rohan Park, Kyung Tavassoli, Peyman Cyrta, Joanna Tagawa, Scott T. Nanus, David M. Beltran, Himisha Molina, Ana M. Khani, Francesca Miguel Mosquera, Juan Xylinas, Evanguelos Shariat, Shahrokh F. Scherr, Douglas S. Rubin, Mark A. Lerner, Seth P. Matin, Surena F. Elemento, Olivier Faltas, Bishoy M. |
author_sort | Robinson, Brian D. |
collection | PubMed |
description | Upper tract urothelial carcinoma (UTUC) is characterized by a distinctly aggressive clinical phenotype. To define the biological features driving this phenotype, we performed an integrated analysis of whole-exome and RNA sequencing of UTUC. Here we report several key insights from our molecular dissection of this disease: 1) Most UTUCs are luminal-papillary; 2) UTUC has a T-cell depleted immune contexture; 3) High FGFR3 expression is enriched in UTUC and correlates with its T-cell depleted immune microenvironment; 4) Sporadic UTUC is characterized by a lower total mutational burden than urothelial carcinoma of the bladder. Our findings lay the foundation for a deeper understanding of UTUC biology and provide a rationale for the development of UTUC-specific treatment strategies. |
format | Online Article Text |
id | pubmed-6611775 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-66117752019-07-08 Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling Robinson, Brian D. Vlachostergios, Panagiotis J. Bhinder, Bhavneet Liu, Weisi Li, Kailyn Moss, Tyler J. Bareja, Rohan Park, Kyung Tavassoli, Peyman Cyrta, Joanna Tagawa, Scott T. Nanus, David M. Beltran, Himisha Molina, Ana M. Khani, Francesca Miguel Mosquera, Juan Xylinas, Evanguelos Shariat, Shahrokh F. Scherr, Douglas S. Rubin, Mark A. Lerner, Seth P. Matin, Surena F. Elemento, Olivier Faltas, Bishoy M. Nat Commun Article Upper tract urothelial carcinoma (UTUC) is characterized by a distinctly aggressive clinical phenotype. To define the biological features driving this phenotype, we performed an integrated analysis of whole-exome and RNA sequencing of UTUC. Here we report several key insights from our molecular dissection of this disease: 1) Most UTUCs are luminal-papillary; 2) UTUC has a T-cell depleted immune contexture; 3) High FGFR3 expression is enriched in UTUC and correlates with its T-cell depleted immune microenvironment; 4) Sporadic UTUC is characterized by a lower total mutational burden than urothelial carcinoma of the bladder. Our findings lay the foundation for a deeper understanding of UTUC biology and provide a rationale for the development of UTUC-specific treatment strategies. Nature Publishing Group UK 2019-07-05 /pmc/articles/PMC6611775/ /pubmed/31278255 http://dx.doi.org/10.1038/s41467-019-10873-y Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Robinson, Brian D. Vlachostergios, Panagiotis J. Bhinder, Bhavneet Liu, Weisi Li, Kailyn Moss, Tyler J. Bareja, Rohan Park, Kyung Tavassoli, Peyman Cyrta, Joanna Tagawa, Scott T. Nanus, David M. Beltran, Himisha Molina, Ana M. Khani, Francesca Miguel Mosquera, Juan Xylinas, Evanguelos Shariat, Shahrokh F. Scherr, Douglas S. Rubin, Mark A. Lerner, Seth P. Matin, Surena F. Elemento, Olivier Faltas, Bishoy M. Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling |
title | Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling |
title_full | Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling |
title_fullStr | Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling |
title_full_unstemmed | Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling |
title_short | Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling |
title_sort | upper tract urothelial carcinoma has a luminal-papillary t-cell depleted contexture and activated fgfr3 signaling |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6611775/ https://www.ncbi.nlm.nih.gov/pubmed/31278255 http://dx.doi.org/10.1038/s41467-019-10873-y |
work_keys_str_mv | AT robinsonbriand uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT vlachostergiospanagiotisj uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT bhinderbhavneet uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT liuweisi uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT likailyn uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT mosstylerj uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT barejarohan uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT parkkyung uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT tavassolipeyman uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT cyrtajoanna uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT tagawascottt uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT nanusdavidm uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT beltranhimisha uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT molinaanam uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT khanifrancesca uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT miguelmosquerajuan uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT xylinasevanguelos uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT shariatshahrokhf uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT scherrdouglass uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT rubinmarka uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT lernersethp uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT matinsurenaf uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT elementoolivier uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling AT faltasbishoym uppertracturothelialcarcinomahasaluminalpapillarytcelldepletedcontextureandactivatedfgfr3signaling |